Providence Therapeutics

Toronto, Canada

Providence Therapeutics is a biotechnology company that develops a personalized mRNA cancer vaccine designed to treat ovarian cancer.

$2.1M raised

Dec 2021

Grant

Biotechnology Health Care Therapeutics Wellness

Top Investors

Bill & Melinda Gates Foundation

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Providence Therapeutics

How much funding has Providence Therapeutics raised?

Providence Therapeutics has raised $2.1M in total funding. The most recent round was Grant. The last funding was announced in December 2021.

Who are Providence Therapeutics's investors?

Providence Therapeutics's investors include Bill & Melinda Gates Foundation.

Where is Providence Therapeutics headquartered?

Providence Therapeutics is headquartered in Toronto, Canada.

What does Providence Therapeutics do?

Providence Therapeutics is a biotechnology company that develops a personalized mRNA cancer vaccine designed to treat ovarian cancer.

What stage is Providence Therapeutics at?

Providence Therapeutics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 7, 2021.

MLA

"Providence Therapeutics — Funding & Investors." VCBacked, December 7, 2021, https://www.vcbacked.co/company/providence-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2021). Providence Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/providence-therapeutics

Wikipedia (cite web)

{{cite web |title=Providence Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/providence-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 7, 2021.